Results 181 to 190 of about 557,930 (311)

Management of dysphagia in head and neck cancer: current and future perspectives. [PDF]

Front Oncol
Schellen C, Konings M, Vergauwen A, Van den Steen L, Baudelet M, Van Nuffelen G.   +5 more
europepmc   +1 more source

A dose‐finding population pharmacokinetic/pharmacodynamic model of ginisortamab, an anti‐gremlin‐1 monoclonal antibody, in patients with solid tumours

British Journal of Clinical Pharmacology, EarlyView.
Aims Ginisortamab, a first‐in‐class human monoclonal antibody for the treatment of advanced solid tumours, binds to gremlin‐1 and restores bone morphogenetic protein signalling. We used pharmacokinetic/pharmacodynamic (PK/PD) modelling to characterize the relationship between ginisortamab dose and serum gremlin‐1 binding, using model‐based simulations ...
Yin Cheong Wong, Luisa Rojas Chavarro, Paul Jones, David Egging, Wanchana Ungphakorn, Marta Valle, Ivan Matthews   +6 more
wiley   +1 more source

Corrigendum: Exploring the dual role of B cells in solid tumors: implications for head and neck squamous cell carcinoma

Frontiers in Immunology, 2023
Jiantong Bao, Jiantong Bao, Annika C. Betzler, Jochen Hess, Jochen Hess, Cornelia Brunner   +5 more
doaj   +1 more source

Surveillance after treatment for head and neck cancer. [PDF]

Curr Opin Otolaryngol Head Neck Surg
Koivunen P.
europepmc   +1 more source

Special Issue "Pathogenesis and Treatments of Head and Neck Cancer". [PDF]

Int J Mol Sci
Tarle M.
europepmc   +1 more source

Personalizing the treatment of head and neck cancer in vitro: The 3D-OTC model. [PDF]

BMC Med
Stögbauer F, Weiser T, Dezfouli AB, Wirth J, Engelmann L, Budczies J, Ourailidis I, Boxberg M, Pigorsch K, Schmidl B, Strittmatter N, Steiger K, Mogler C, Wollenberg B.   +13 more
europepmc   +1 more source

Cold atmospheric plasma‐mediated tumor microenvironment remodeling for cancer treatment

BMEMat, EarlyView.
Schematic presentation of CAP‐mediated TME remodeling. This review summarizes recent efforts in cold atmospheric plasma (CAP) application in cancer treatment, highlighting the anticancer potential of CAP, molecular mechanisms, and future perspectives for further improvement and clinical translation.
Israr Khan, Qiujie Fang, Cao Fei, Ziyuan Wang, Zhaowei Chen, Guojun Chen, Zhiming Xu, Shu Xu, Zhitong Chen   +8 more
wiley   +1 more source

Perioperative immunonutrition and outcomes in head and neck cancer surgery - a randomized clinical trial: Effects of perioperative immunonutrition in patients with head and neck cancer. [PDF]

Medicine (Baltimore)
Başmisirli E, Başmisirli E, Şahin H, Yüce İ.   +3 more
europepmc   +1 more source

Reprogramming tumor immune microenvironment by ultrasound‐responsive nanoplatforms for enhanced cancer immunotherapy

BMEMat, EarlyView.
Ultrasound‐responsive nanoplatforms reprogram the tumor immune microenvironment by targeting tumor cells, immune cells, and non‐immune stromal cells to enhance the efficacy of cancer immunotherapy. Abstract Cancer immunotherapy represents a significant advancement in cancer treatment by enhancing the specific recognition and elimination of cancer cells.
Shilong Zhao, Rui Qu, Zan Dai, Xiqun Jiang, Xu Zhen   +4 more
wiley   +1 more source

Immune biomarkers for head and neck cancer. [PDF]

Cancer Immunol Immunother
Sobhani N, D'Angelo A, Kugeratski FG, Nguyen T, Morris RM, Roudi R, Kia N, Pianta L, Morello R, Winter S, Generali D, Membrino A.   +11 more
europepmc   +1 more source